Fascia Lata Allograft Versus Subepithelial Connective Tissue Grafts in the Peri-Implant Mucosal Thickness Enhancement. — Fascia Lata  

Implant Tissue Failure Clinical Trial

Official title: Fascia Lata Allograft Versus Subepithelial Connective Tissue Grafts in the Peri-Implant

Status Completed

Clinical Trial Summary

The aim of this, randomized clinical trial is to determine the clinical efficacy of fascia lata allograft in terms of peri-implant mucosal augmentation, as compared to autologous sub epithelial connective tissue graft, clinically and histologically in human adults .

Clinical Trial Description

The aim of this, randomized clinical trial is to determine the clinical efficacy of fascia lata allograft in terms of peri-implant mucosal augmentation, as compared to autologous sub epithelial connective tissue graft, clinically and histologically in human adults . The hypothesis of the study is that a similar gain in peri implant mucosal thicknesses will be obtained in sites treated by either a sub epithelial connective tissue graft or a newly developed fascia lata allograft in clinically and histologically in human. The objective of this study will be to evaluate the efficacy of the peri-implant mucosal thickness enhancement following either subepithelial connective tissue grafts or human Fascia Lata Allograft placed simultaneously with dental implant placement. Sixteen sites that are indicated for peri-implant mucosal augmentation at the time of implant placement will be selected. Participants will be randomized to the control (simultaneous SCTGs) or test (simultaneous FLA) group. ;

Related Conditions & MeSH terms

• Implant Tissue Failure

• NCT number: NCT04679922
• Study type: Interventional
• Source: Tanta University
• Status: Completed
• Phase: N/A
• Start date: December 10, 2019
• Completion date: November 18, 2020